RAPAd®

    The RAPAd® method of Adenovirus construction, developed by ViraQuest Inc. scientists, has been used by other scientists around the world.

    Request Quote

    Confidentiality

     

    Learn More

    Quality Control

    Plaque forming units guarantee. Non-detectable RCA.

    Learn More

    Turnaround Time

    Sub-cloning to finished particles in about four weeks.

    Learn More

    Dual Expressers

    Multiple transgene expression in a single virus.

    Learn More

Tag Archives: Cancer

TP53 silencing bypasses growth arrest of BRAFV600E-induced lung tumor cells in a two-switch model of lung tumorigenesis

Authors: Shai A, Dankort D, Juan J, Green S, McMahon M
Citation: Cancer Res. 2015 Aug 1;75(15):3167-80

read more

The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic

Authors: Gabitzsch ES, Tsang KY, Palena C, David JM, Fantini M, Kwilas A, Rice AE, Latchman Y, Hodge JW, Gulley JL, Madan RA, Heery CR, Balint JP Jr, Jones FR, Schlom J
Citation: Oncotarget. 2015 Oct 13;6(31):31344-59

read more

An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression

Authors: Rice AE, Latchman YE, Balint JP, Lee JH, Gabitzsch ES, Jones FR.
Citation: Cancer Gene Ther. 2015 Sep;22(9):454-62

read more

Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion

Authors: Tacconi C, Correale C, Gandelli A, Spinelli A, Dejana E, D'Alessio S, Danese S
Citation: Gastroenterology. 2015 Jun;148(7):1438-51.e8

read more

Method and composition to increase radiation-induced tumor therapeutic effects

Authors: Richard N. Kolesnick, Branka Stancevic, Michel Sadelain, Zvi Fuks, Nira Varda-Bloom, Dror Harats
Citation:

read more

A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction

Authors: Carotenuto, M., de Antonellis, P., Chiarolla, C.M. et al
Citation: Naunyn-Schmiedeberg's Arch Pharmacol (2015) 388: 257

read more

Redox signalling to nuclear regulatory proteins by reactive oxygen species contributes to oestrogen-induced growth of breast cancer cells

Authors: Okoh VO, Garba NA, Penney RB, Das J, Deoraj A, Singh KP, Sarkar S, Felty Q, Yoo C, Jackson RM, Roy D.
Citation: Br J Cancer. 2015 May 12;112(10):1687-702

read more

Diminished WNT→ β-catenin→ c-myc signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors

Authors: Juan J, Muraguchi T, Iezza G, Sears RC, McMahon M
Citation: Genes Dev. 2014 Mar 15;28(6):561-75

read more

Demethylating drugs as novel analgesics for cancer pain

Authors: Viet CT, Dang D, Ye Y, Ono K, Campbell RR, Schmidt BL
Citation: Clin Cancer Res. 2014 Sep 15;20(18):4882-4893

read more